AMGN
AMGN clinical trials: AMGEN INC
Every trial on ClinicalTrials.gov where AMGEN INC is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 1,622
- Trials linked
- 1,048
- As lead sponsor
- 574
- As collaborator
- 10
- Primary completions as lead sponsor, next 90 days
AMGN on the catalyst calendar · AMGN registry changes
- Primary completion Jul 24, 2026ActualPhase 1NCT07422285Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous DoseAmgen · Healthy ParticipantsCompletedAMGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 14, 2029Sponsor estimatePhase 3NCT07700238A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Newly Diagnosed Previously Untreated Primary...Amgen · Primary Immune ThrombocytopeniaRecruitingAMGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 3, 2028Sponsor estimatePhase 3NCT07575399Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in...Amgen · Obesity or OverweightRecruitingAMGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 19, 2028Sponsor estimatePhase 3NCT07366086Pediatric Safety Follow-up Study of Prior Treatment With Romosozumab for Osteogenesis ImperfectaAmgen · Osteogenesis ImperfectaRecruitingAMGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 10, 2031Sponsor estimatePhase 2NCT07222553Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Inebilizumab in Pediatric Participants With IgG4-RDAmgen · Immunoglobulin G4-related DiseaseRecruitingAMGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 30, 2027Sponsor estimatePhase 3NCT03969329A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving HemodialysisAmgen · Secondary HyperparathyroidismRecruitingAMGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 31, 2036Sponsor estimatePhase 4NCT06072482A Study to Evaluate Avacopan in Participants With ANCA-associated VasculitisAmgen · Antineutrophil Cytoplasmic Antibody-associated VasculitisRecruitingAMGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 30, 2027Sponsor estimatePhase 3NCT05920356A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in...Amgen · Non-Small Cell Lung Cancer (NSCLC)RecruitingAMGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 20, 2031Sponsor estimatePhase 3NCT07136012OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And Lipoprotein(a) Reduction to Prevent First Major Cardiovascular EventsAmgen · Cardiovascular DiseaseRecruitingAMGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 31, 2027Sponsor estimatePhase 3NCT07614776A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With...Amgen · Neovascular Age-related Macular DegenerationRecruitingAMGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 27, 2027Sponsor estimatePhase 1NCT07140900Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in...Amgen · Metastatic Hormone-sensitive Prostate Cancer (mHSPC)Active, not recruitingAMGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 17, 2027Sponsor estimatePhase 1NCT07745907A Phase 1 Trial of AMG 691 in Healthy Chinese and Japanese VolunteersAmgen · Healthy ParticipantsActive, not recruitingAMGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 29, 2027Sponsor estimatePhase 4NCT05284747EVOLVE-MI: EVOLocumab Very Early After Myocardial InfarctionAmgen · Cardiovascular DiseaseActive, not recruitingAMGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 28, 2030Sponsor estimatePhase 1NCT04221542Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate CancerAmgen · Prostate CancerRecruitingAMGNLeadONCCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 16, 2027Sponsor estimatePhase 3NCT07871409Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or OverweightAmgen · ObesityRecruitingAMGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2, 2030Sponsor estimatePhase 3NCT06211036Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC)...Amgen · Extensive-Stage Small-Cell Lung CancerActive, not recruitingAMGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 6, 2028Sponsor estimatePhase 3NCT07866066Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 DiabetesAmgen · Diabetes Mellitus, Type 2RecruitingAMGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 26, 2027Sponsor estimatePhase 1NCT07921316Comparing the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous...Amgen · ObesityNot yet recruitingAMGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 17, 2036Sponsor estimatePhase 3NCT05767047A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic ArthritisAmgen · Behçet's DiseaseRecruitingAMGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 31, 2027Sponsor estimatePhase 1NCT03319940Study Evaluating Safety, Tolerability and Pharmacokinetics (PK) of Tarlatamab in Adults With Small Cell Lung Cancer (SCLC)Amgen · Small Cell Lung CarcinomaActive, not recruitingAMGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 30, 2031Sponsor estimatePhase 3NCT07598825A Trial of Inebilizumab in Participants With Autoimmune HepatitisAmgen · Autoimmune HepatitisRecruitingAMGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 10, 2027Sponsor estimatePhase 1NCT07908641Comparing the Extent to Which Apremilast is Made Available in the Body After Administration as an Extended-release or Immediate-release...Amgen · PsoriasisNot yet recruitingAMGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 10, 2027Sponsor estimatePhase 1NCT06637371A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With...Amgen · AsthmaActive, not recruitingAMGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 6, 2026ActualPhase 2NCT06054113Study of Blinatumomab Administration in Chinese Pediatric Participants With Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia...Amgen · B Precursor Acute Lymphoblastic LeukemiaActive, not recruitingAMGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 26, 2030Sponsor estimatePhase 1NCT07297979Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)Amgen · Ewing SarcomaRecruitingAMGNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 25 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerShowing the first 25 trials. There are 1,597 more in this window; the full list is part of TrialScanner.
Unlock with TrialScanner